GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
+23.09%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$824M
AUM Growth
+$824M
Cap. Flow
-$120M
Cap. Flow %
-14.53%
Top 10 Hldgs %
81.45%
Holding
40
New
5
Increased
9
Reduced
8
Closed
11

Top Buys

1
TCDA
Tricida, Inc. Common Stock
TCDA
$56.2M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$30.9M
3
ZYME icon
Zymeworks
ZYME
$23.1M
4
TVTX icon
Travere Therapeutics
TVTX
$20.2M
5
ZGNX
Zogenix, Inc.
ZGNX
$18.8M

Top Sells

1
GBT
Global Blood Therapeutics, Inc.
GBT
$62.5M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$48.5M
3
UTHR icon
United Therapeutics
UTHR
$44.6M
4
ARRY
Array Biopharma Inc
ARRY
$43.9M
5
PBYI icon
Puma Biotechnology
PBYI
$34.9M

Sector Composition

1 Healthcare 98.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARRY
26
DELISTED
Array Biopharma Inc
ARRY
– –
-1,800,000
Closed -$43.9M
EPZM
27
DELISTED
Epizyme, Inc
EPZM
– –
-2,173,913
Closed -$26.9M
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-1,180,000
Closed -$62.5M
ICPT
29
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
0
– –
CBAY
30
DELISTED
Cymabay Therapeutics
CBAY
– –
-998,841
Closed -$13.3M
UTHR icon
31
United Therapeutics
UTHR
$17.7B
– –
-379,832
Closed -$44.6M
SVRA icon
32
Savara
SVRA
$591M
– –
-660,366
Closed -$4.87M
SLDB icon
33
Solid Biosciences
SLDB
$448M
– –
0
– –
PBYI icon
34
Puma Biotechnology
PBYI
$258M
– –
-900,000
Closed -$34.9M
NVAX icon
35
Novavax
NVAX
$1.2B
– –
0
– –
KRYS icon
36
Krystal Biotech
KRYS
$4.35B
– –
-492,100
Closed -$16.2M
FGEN icon
37
FibroGen
FGEN
$48.4M
– –
0
– –
CTMX icon
38
CytomX Therapeutics
CTMX
$350M
– –
-959,077
Closed -$10.3M
BCRX icon
39
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
-5,955,762
Closed -$48.5M
AKBA icon
40
Akebia Therapeutics
AKBA
$827M
– –
-131,531
Closed -$1.08M
1
2